Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "Competitor Analysis of Intraocular Lens Market, Forecast by Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and ...

The newly approved technology delivers low-dose microcurrents through closed eyelids to stimulate retinal cells. Canadian medical device company MacuMira Medical Devices recently introduced the first ...

Clareon Panoptix Pro IOL achieves 94% light utilization, enhancing light distribution and optical image contrast for improved patient outcomes. The IOL offers +2.17 diopter intermediate and +3.25 ...

The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the ...

TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens ...

The new full visual range (*1) IOL offers high-quality and continuous vision with unmatched range. ($6,16) This will allow patients to see clearly from far to near and in between, minimizing their ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...

Narrow-moat Alcon reported solid fourth-quarter earnings and ended 2024 on strong footing. Total sales of $2.5 billion were up 7.1% year over year thanks to broad-based growth across the portfolio.

The following is a summary of “Visual Outcomes and Quality of Vision After Bilateral Implantation of a Hydrophobic Acrylic Trifocal Intraocular Lens,” published in the January 2025 issue of ...

Oppenheimer has upgraded Alcon Inc (NYSE:ALC) following firm first-quarter earnings and several new drivers coming into view. The analyst sees a new opportunity in glaucoma with the announced ...